Andrew Summers of Summers Value Partners on healthcare, biotech $GILD, $QURE and $ELMD | S08 E02

Andrew Summers of Summers Value Fund, a healthcare specialist, discusses his concentrated, long-term investment approach, focusing on special situations within the healthcare sector. He highlights the complexity of healthcare due to the ever-changing regulatory environment and the significant role of payers. Summers points out that healthcare, particularly biotech, appears undervalued relative to the broader market, driven by innovation cycles and potential M&A activity, especially with large pharmaceutical companies facing patent expirations. He also touches on the promise of GLP-1 drugs and shares insights from his experience with activism in healthcare and his board positions in medical device companies, including Restore3D, which focuses on personalized orthopedics.